Objectives: To analyse the metallo-b-lactamase (MBL) genes and their genetic environments in clinical isolates of Achromobacter xylosoxidans.
Introduction
Achromobacter xylosoxidans is a non-fermenting aerobic Gramnegative bacillus that is ubiquitous in the environment. 1 Although this organism rarely causes infections in humans, certain isolates can cause life-threatening illnesses, especially in immunocompromised individuals. 2 Most Achromobacter infections are acquired in nosocomial settings and frequently can be traced to a common hospital source. 2 The clinical importance of this species has increased in recent years, as it has become a potential cause of nosocomial outbreaks and multidrug-resistant (MDR) infections. 3 In addition, metallo-b-lactamase (MBL) production by this species has been detected in the last decade. 4 Among A. xylosoxidans strains, evidence for the existence of VIM-type MBLs, including their genetic environments and contributions to carbapenem resistance, has been reported. 4 However, little is known regarding the genetic environment of the IMP-type MBL genes and their association with horizontal transfer in this species. 4 Thus, the objective of this study was to understand the genetic environments of the IMP-type MBL genes and their dissemination across A. xylosoxidans.
Materials and methods

Bacterial isolates, species identification and molecular typing
From January 2004 to December 2010, four MBL-positive A. xylosoxidans isolates were identified at Kyoto University Hospital in Japan. Primary identification of these isolates and MBL screening test were performed as described elsewhere. 5 Only one MBL-positive isolate per patient was included. Species identification was confirmed by 16S ribosomal RNA # The Author 2012. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com J Antimicrob Chemother 2012; 67: 2110 -2113 doi:10.1093/jac/dks179 Advance Access publication 10 May 2012 gene sequencing. 6 Molecular typing was performed using PFGE with XbaI (TaKaRa) and cluster analysis was performed as described previously with certain modifications. 7 
Antimicrobial susceptibility
Antimicrobial susceptibility testing was performed using the broth microdilution method with dry plates (Eiken Chemical) according to the 2012 CLSI guidelines. The Etest was also employed (see Table 1 ).
PCR amplification of MBL and integrase genes, and analysis of integron gene cassettes PCR screening for MBL (bla IMP-1 , bla IMP-2, bla VIM-1 , bla VIM-2 and bla NDM-1 ) and integrase (intI1, intI2 and intI3) genes was performed. For the detection of class 1 integron gene cassettes, PCR amplification (integron PCR), cloning and sequencing were performed as described elsewhere.
5 PCR amplification and sequencing were performed to determine the Pc promoter variant. The primers designed for this study are shown in Table S1 (available as Supplementary data at JAC Online).
Analysis of class 1 integrons carrying multiple bla IMP-1 cassettes
Primer walking was impossible due to the bla IMP-1 cassette repetitions in the integron gene cassettes detected from KUN3391. Therefore, a recombinant plasmid containing the 5 kb integron PCR product was digested with HincII and electrophoresed on a 0.7% agarose gel. Each 2 kb and 600 bp fragment was purified using a QIAquick w Gel Extraction Kit (QIAGEN). The purified fragments were subcloned into the pUC19 vector (TaKaRa) treated with HincII and the recombinant plasmids were electroporated into Escherichia coli DH5a (TaKaRa). We identified the genetic array of bla IMP-1 -nit1/nit2-catB3-bla IMP-1 ( 2 kb) and the array of bla IMP-1 -bla IMP-1 ( 600 bp).
PCR was performed with primers for intI1 (primer A3) and nit1 (A4) as well as catB3 (A5) and the 3 ′ -conserved segment (CS) (A6) under the same conditions as the integron PCR (see Figure 1 ). The arrays for intI1-bla IMP-1 -bla IMP-1 -nit1 ( 1.9 kb) and catB3-bla IMP-1 -bla IMP-1 -3 ′ -CS ( 2.2 kb) were identified. To confirm the nucleotide sequences between the sequential bla IMP-1 gene cassettes, each PCR product was cloned as described elsewhere. 5 Each recombinant plasmid was digested with HincII and electrophoresed; fragments with a size of 600 bp were subcloned and sequenced as described above.
Plasmid profile analysis and Southern hybridization
Plasmid DNA from each A. xylosoxidans isolate was prepared using the PureLink TM HiPure Plasmid Filter Midiprep Kit (Invitrogen). Samples of plasmid DNA digested with EcoRI were electrophoresed on 0.7% agarose gels. The DNA was transferred from the gel to a Hybribond N+ membrane (GE Healthcare) using a vacuum transfer apparatus and UV cross-linked, as described by the manufacturer (Bio-Rad). The DNA on the membrane was hybridized with a 587 bp digoxigenin-labelled bla IMP-1 probe or a 678 bp digoxigenin-labelled bla IMP-19 probe. Probe generation and hybridization were performed using the DIG DNA Labelling and Detection Kit (Roche Applied Science).
Conjugation and transformation experiments
An in vitro conjugation assay was performed using the liquid mating method, as previously described. 8 Azide-resistant E. coli ME8067 was used as the recipient, and MacConkey agar with azide (100 mg/L) and ceftazidime (2 mg/L) was used as the selective agar.
Plasmid DNA prepared from each A. xylosoxidans isolate was electroporated into E. coli HST08 (TaKaRa). Transformants were selected on Luria-Bertani (LB) agar containing ceftazidime (4 mg/L). Plasmids from the transformants were prepared as described above. MBL genes were detected by PCR, and the EcoRI restriction patterns of plasmid DNA from parental strains and transformants were compared.
Nucleotide sequence accession numbers
The nucleotide sequences reported in this paper have been submitted to the DNA Data Bank of Japan (DDBJ; http://www.ddbj.nig.ac.jp/) and assigned the accession numbers AB698822, AB698823, AB698824 and AB698825.
Results and discussion
Bacterial isolates, species identification and molecular typing
During the study period, 36 clinical isolates of A. xylosoxidans were detected at our hospital. Four (11.1%) of these isolates (KUN2115, KUN3391, KUN4193 and KUN4507) were positive for MBL production. These isolates were sporadically recovered from clinical specimens. The A. xylosoxidans KUN4507 isolate caused a bloodstream infection and the other isolates were considered colonizers. The PFGE analysis with XbaI digestion did not demonstrate any clonal relationships between these A. xylosoxidans isolates.
MBL genes and integron gene cassettes
Three of the four isolates (KUN2115, KUN3391 and KUN4193) harboured the bla IMP-1 gene, and the bla IMP-19 gene was detected in one isolate (KUN4507). Each of the isolates harboured the class 1 integrase gene (intI1).
The bla IMP-1 genes detected in this study were located within class 1 integrons and four gene cassette arrays were found, including orf1-bla IMP-1 -aacA4 from KUN2115, bla IMP-1 -bla IMP-1 -nit1/nit2-catB3-bla IMP-1 -bla IMP-1 from KUN3391, aacA4-bla IMP-1 from KUN4193 and bla IMP-19 from KUN4507 ( Figure 1) . A strong promoter (PcS variant) was found in the class 1 integron detected from KUN4507 and class 1 integrons from other strains contained weak promoters (PcW variant).
The bla IMP-1 gene was first isolated from Serratia marcescens in Japan and has since been found in many species. 4 Only one report has revealed the genetic environment of the bla IMP-1 gene in A. xylosoxidans (GenBank accession number EF027105) and the previously described integron gene cassette array (bla IMP-1 -aacA4-aadA5) was distinct from the genetic arrays reported in our study.
The genetic array of bla IMP-1 -bla IMP-1 -nit1/nit2-catB3-bla IMP-1 -bla IMP-1 was confirmed based on the results of sequence analysis of HincII digestion fragments. Although a class 1 integron with three aacA4 gene cassettes and the potential for homologous recombination was previously reported, 9 class 1 integrons containing multiple copies of the bla IMP-1 MBL gene cassette have not been reported. However, the functional significance of this gene cassette array remains unclear.
Here, we present the first known report of the bla IMP-19 gene in A. xylosoxidans. The bla IMP-19 gene has also been identified in IMP-type metallo-b-lactamases in A. xylosoxidans 2111 JAC other species in France and Japan. 5, 10 The bla IMP-19 gene was detected in Acinetobacter species in our hospital, although the integron gene cassette array results presented here differed from previously described arrays. 5 
Plasmid analysis
The EcoRI digestion of the plasmid DNA obtained from each A. xylosoxidans isolate and the Southern hybridization experiments using digoxigenin-labelled DNA probes for each Yamamoto et al.
MBL gene showed that all of the MBL genes were found on plasmids with different restriction patterns ( Figure S1 , available as Supplementary data at JAC Online). These findings suggested that the four identified A. xylosoxidans isolates did not have a clonal relationship and had acquired the MBL genes via different plasmids. Conjugation experiments were unsuccessful. Therefore, we used electroporation to transform plasmid DNA obtained from each A. xylosoxidans strain into E. coli HST08. All of the plasmids containing MBL genes could be successfully transformed into E. coli HST08. Of the three isolates harbouring the bla IMP-1 gene, the EcoRI restriction patterns of plasmid DNA from the parental strains and the transformants were identical. For the KUN4507 isolate, the EcoRI restriction patterns differed between the parental strain and the transformants ( Figure S1 ). Two additional restriction fragments were present for the plasmids from the KUN4507 parental strain.
Antimicrobial susceptibility
The antimicrobial susceptibility profiles of the A. xylosoxidans isolates and transformants are shown in Table 1 . All isolates were resistant to carbapenems and fluoroquinolones. The MICs of carbapenem for the transformants were higher than those of the E. coli HST08 reference strain. The KUN4507 transformant in particular had a high carbapenem MIC. The Pc promoter variant may have contributed to this finding. Each of the isolates, except for KUN3391, showed a high level of resistance to aminoglycosides. MICs of aminoglycosides for the transformants were approximately the same as those of the reference strain. Both the parental KUN3391 strain, which harbours the catB3 gene, and its transformant demonstrated high MICs with respect to chloramphenicol.
Conclusions
In conclusion, to our knowledge, this study is the first to demonstrate the genetics of IMP-type MBL genes in A. xylosoxidans. Each isolate had a different plasmid-borne class 1 integron containing an IMP-type MBL gene. Interestingly, one isolate harboured four copies of the bla IMP-1 cassette located within a class 1 integron. The present findings provide evidence that IMP-type MBL genes on plasmids may be associated with horizontal transfer and could contribute to the carbapenem resistance of A. xylosoxidans. Thus, A. xylosoxidans could represent a clinical threat as both a pathogen and a reservoir of resistance genes.
